MMMałgorzata Mazur

Małgorzata Mazur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Małgorzata Mazur has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Kabłak-Ziembicka

    Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, św. Anny 12, 31-007 Kraków, Poland

    2 shared publications
  • Anna Maciak

    The Military Clinical Hospital with Polyclinic in Krakow, Wrocławska 1/3 Street, 30-901

    1 shared publication
  • Jakub Podolec

    Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, św. Anny 12, 31-007 Kraków, Poland

    1 shared publication
  • Klaudia Piwowar

    Department of Interventional Cardiology, Institute of Cardiology, St. John Paul II Hospital, Prądnicka 80, 31-202 Kraków, Poland

    1 shared publication
  • Larysa Bielecka

    Department of Cardiac and Vascular Diseases, Krakow Specialist Hospital Named After St. John Paul II, ul. Prądnicka 80, 31-202 Krakow, Poland

    1 shared publication
  • Lukasz Tekieli

    Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Krakow, Poland; Cardiovascular Catheterization Laboratory, St John Paul II Hospital, Krakow, Poland; Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland

    1 shared publication

Latest Publications

  • Open Access

    Subclinical Atherosclerosis, Hyperlipidemia and New-Onset Diabetes Should Not Be Ignored Despite Initial Angiographic Exclusion of Significant Atherosclerotic Occlusive Arterial Disease

    by Magdalena Wawak, Łukasz Tekieli, Marcin Piechocki, Piotr Odrowąż-Pieniążek, Magdalena Kaźnica-Wiatr, Małgorzata Mazur, Anna Maciak-Pawłucka, Monika Komar, Tadeusz Przewłocki, Anna Kabłak-Ziembicka

    Background and Objectives: Despite the presence of atherosclerosis risk factors and symptoms associated with occlusive atherosclerotic cardiovascular disease (ASCVD), up to 30% of individuals do not present significant atherosclerotic lesions at the point of diagnostic evaluation. Those in whom ASCVD was ruled out once might be believed to be at low risk of future major cerebral and cardiac events (MACCEs). Despite this, they might still have some residual risk for MACCEs. Therefore, in the present study we aimed to evaluate risk factors for atherosclerosis progression to the stage of occlusive arterial disease in patients with cardiovascular risk factors but initially free from significant ASCVD. Materials and Methods: Between March 2012 and February 2014, a total of 686 consecutive patients presenting with clinical suspicion of significant coronary artery disease were evaluated. The actual status of atherosclerosis burden was verified in four major arterial territories (coronary, carotid, renal, lower limb arteries) with the use of angiography, computed tomography and ultrasonography. For the present study purpose, 188 (27.4%) patients were enrolled, in whom significant ASCVD (in any of the examined territories) was ruled out. In all patients, the incidence and severity of atherosclerotic risk factors, carotid intima–media complex thickness (CIMT) and carotid plaque presence were evaluated during first hospital admission. A ten-year follow-up period for a composite endpoint of MACCEs was included. Univariate and multivariate Cox proportional hazard analyses with the Simon–Makuch method for new-onset type 2 diabetes mellitus (T2DM) were performed for MACCEs. Results: MACCEs occurred in 30 (16%) of 188 patients, including 5 cardiovascular deaths, 19 non-fatal myocardial infarctions, and 6 non-fatal ischemic strokes, in a median of 48 (Q1; Q3: 25; 86) months. Univariate Cox proportional hazard analysis revealed that individuals who presented with baseline LDL cholesterol > 3.2 mmol/L, CIMT > 1 mm, carotid plaque, or experienced new-onset T2DM were predisposed to MACCE with hazard ratios (HRs) of 3.21 (p = 0.003), 3.82 (p = 0.001), 5.41 (p < 0.001), and 36.89 (p < 0.001), respectively. In multivariate Cox analysis, its associations with MACCEs were retained (HRs between 2.19 and 21.47), respectively. Conclusions: Our findings support the need for continued risk factor optimization despite the initial exclusion of obstructive ASCVD. In this study, we identified new-onset T2DM, initial LDL cholesterol, and the presence of subclinical atherosclerosis as risk factors for MACCEs.


  • Open Access

    Obstructive Sleep Apnea in Patients with Significant Coronary Artery Disease: An Underdiagnosed Condition

    by Monika Kowalik-Pandyra, Klaudia Piwowar, Michał Tworek, Larysa Bielecka, Małgorzata Mazur, Anna Kabłak-Ziembicka, Jakub Podolec

    Background: Obstructive sleep apnoea (OSA) is a highly prevalent yet underdiagnosed disorder in patients with cardiovascular disease. Growing evidence suggests a pathophysiological link between OSA and coronary artery disease (CAD); however, the relationship between OSA severity and anatomical complexity of coronary lesions remains incompletely understood. Aim: The aim of this study is to assess the prevalence of OSA in patients undergoing coronary angiography and to evaluate the association between sleep-disordered breathing parameters and the severity of CAD expressed by the SYNTAX score. Methods: This prospective study enrolled 103 consecutive patients referred for invasive coronary angiography. All participants underwent overnight type III cardiorespiratory polygraphy. OSA severity was classified according to the Apnea–Hypopnea Index (AHI). The anatomical complexity of CAD was assessed using the SYNTAX score. Linear regression analyses were performed to determine associations between polysomnographic parameters and SYNTAX score. Results: Significant CAD was diagnosed in 74.8% of patients. OSA was highly prevalent, with severe OSA observed in 36.4% of patients with significant CAD compared to 3.8% in those without significant stenoses (p = 0.003). Patients with significant CAD had higher AHI (18.8 vs. 13.5 events/h; p = 0.003), higher oxygen desaturation index (ODI) (19.3 vs. 12.9 events/h; p = 0.003), and greater mean oxygen desaturation (4.1% vs. 3.8%; p = 0.008). In multivariable regression analysis, AHI (B = 0.329; 95% CI [0.083, 0.576]; p = 0.009) and nicotinism (B = 8.693; 95% CI [2.573, 14.814]; p = 0.006) independently predicted higher SYNTAX scores. Interestingly, each 1% increase in snoring percentage was associated with a 0.203-point reduction in SYNTAX score (95% CI [−0.339, −0.068]; p = 0.004). Conclusions: OSA is highly prevalent in patients undergoing coronary angiography and is independently associated with greater anatomical complexity of CAD. Sleep-disordered breathing, particularly AHI and nocturnal hypoxemia, may represent important non-traditional risk markers of advanced coronary atherosclerosis. Systematic screening for OSA should be considered in patients with suspected or confirmed CAD.